# From Gene to Pathways: Understanding Novel Vps51 Variant and Its Cellular Consequences

**Authors:** Damla Aygun, Didem Yücel Yılmaz

PMC · DOI: 10.3390/ijms26125709 · International Journal of Molecular Sciences · 2025-06-14

## TL;DR

A new VPS51 gene variant in two siblings causes developmental and metabolic issues, affecting cellular transport and autophagy.

## Contribution

This study is the first to perform a comparative proteomic analysis of a novel VPS51 variant and its impact on organelle communication.

## Key findings

- The VPS51 variant leads to reduced gene and protein expression, along with altered autophagy-related gene expression.
- Proteomic profiling identified 585 differentially expressed proteins, affecting vesicular trafficking, lysosomal function, and mitochondrial metabolism.
- Increased mitochondria–lysosome contact sites suggest impaired organelle communication due to VPS51 dysfunction.

## Abstract

Disorders of vesicular trafficking and genetic defects in autophagy play a critical role in the development of metabolic and neurometabolic diseases. These processes govern intracellular transport and lysosomal degradation, thereby maintaining cellular homeostasis. In this article, we present two siblings with a novel homozygous variant in VPS51 (Vacuolar protein sorting 51) gene (c.1511C>T; p.Thr504Met), exhibiting developmental delay, a thin corpus callosum, severe intellectual disability, epilepsy, microcephaly, hearing loss, and dysphagia. This study aimed to investigate the effects of the novel VPS51 gene variation at the RNA and protein level in fibroblasts derived from patients. A comparative proteomic analysis, which has not been previously elucidated, was performed to identify uncharacterized proteins associated with vesicular trafficking. Furthermore, the impact of disrupted pathways on mitochondria–lysosome contact sites was assessed, offering a thorough pathophysiological evaluation of GARP/EARP (Golgi Associated Retrograde Protein / Endosome Associated Retrograde Protein) complex dysfunction. An analysis of mRNA expression indicated decreased levels of the VPS51 gene, alongside modifications in the expression of autophagy-related genes (LC3B, p62, RAB7A, TBC1D15). Western blotting demonstrated a reduction in VPS51 and autophagy-related protein levels. Proteomic profiling revealed 585 differentially expressed proteins, indicating disruptions in vesicular trafficking, lysosomal function, and mitochondrial metabolism. Proteins involved in mitochondrial β-oxidation and oxidative phosphorylation exhibited downregulation, whereas pathways related to glycolysis and lipid synthesis showed upregulation. Live-cell confocal microscopy revealed a notable increase in mitochondria–lysosome contact sites in patient fibroblasts, suggesting that VPS51 protein dysfunction contributes to impaired organelle communication. The findings indicate that the novel VPS51 gene variation influences intracellular transport, autophagy, and metabolic pathways, offering new insights into its involvement in neurometabolic disorders.

## Linked entities

- **Genes:** VPS51 (VPS51 subunit of GARP complex) [NCBI Gene 738], MAP1LC3B (microtubule associated protein 1 light chain 3 beta) [NCBI Gene 81631], GTF2H1 (general transcription factor IIH subunit 1) [NCBI Gene 2965], RAB7A (RAB7A, member RAS oncogene family) [NCBI Gene 7879], TBC1D15 (TBC1 domain family member 15) [NCBI Gene 64786]
- **Proteins:** VPS51 (VPS51 subunit of GARP complex)

## Full-text entities

- **Genes:** MAP1LC3B (microtubule associated protein 1 light chain 3 beta) [NCBI Gene 81631] {aka ATG8F, LC3B, MAP1A/1BLC3, MAP1LC3B-a}, RAB7A (RAB7A, member RAS oncogene family) [NCBI Gene 7879] {aka CMT2B, PRO2706, RAB7}, NUP62 (nucleoporin 62) [NCBI Gene 23636] {aka IBSN, SNDI, p62}, VPS51 (VPS51 subunit of GARP complex) [NCBI Gene 738] {aka ANG2, ANG3, C11orf2, C11orf3, FFR, PCH13}, LRRC32 (leucine rich repeat containing 32) [NCBI Gene 2615] {aka CPPRDD, D11S833E, GARP}, TBC1D15 (TBC1 domain family member 15) [NCBI Gene 64786] {aka RAB7-GAP}
- **Diseases:** neurometabolic disorders (MESH:D009358), epilepsy (MESH:D004827), microcephaly (MESH:D008831), dysphagia (MESH:D003680), intellectual disability (MESH:D008607), developmental delay (MESH:D002658), thin corpus callosum (MESH:C538335), hearing loss (MESH:D034381), metabolic and neurometabolic diseases (MESH:D008659)
- **Chemicals:** lipid (MESH:D008055)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** c.1511C>T

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12193522/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12193522/full.md

## References

56 references — full list in the complete paper: https://tomesphere.com/paper/PMC12193522/full.md

---
Source: https://tomesphere.com/paper/PMC12193522